In this study, the use of SphK1 inhibitors effectively increased the LVEF, LVFS, and E/A of MI rats, so inhibition of SphK1/S1P may become one of the methods to improve the cardiac function of MI rats. Here, SPHK1 is linked to myocardial infarction.